HeiLongJiang ZBD Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. is a large Shanghai Stock Exchange listed enterprise (stock code: 603567) committed to providing high-quality products and services for human health. As one of the top 100 pharmaceutical enterprises in China, the company focuses on the development direction of innovation and creation, high quality, and high technology. Its business covers four major sectors: technology research and development, pharmaceutical industry, traditional Chinese medicine industry, and financial investment. It is one of the most innovative pharmaceutical enterprises in China's pharmaceutical industry. |
| Headquarter | Jixi City |
| Establish Date | 10/28/1996 |
| Listed Code | 603567.SH |
| Listed Date | 4/24/2015 |
| Chairman | Fang Tonghua. |
| CEO | Yan Jiujiang. |
| Website | www.zbdzy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
